Jiangsu Hengrui Medicine Co., Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jiangsu Hengrui Medicine Co., Ltd. with three other
companies in this sector in China:
Shanghai Shyndec Pharmaceutical Co Ltd
sales of 9.12 billion Chinese Renmimbi [US$1.33 billion]
of which 49%
was Drug Products),
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
(8.98 billion Chinese Renmimbi [US$1.30 billion]
of which 95%
was Pharmaceutical), and
North China Pharmaceutical, Limited
(8.08 billion Chinese Renmimbi [US$1.17 billion]
of which 43%
was Chemical Preparation Medicine).
During the year ended December of 2016, sales at
Jiangsu Hengrui Medicine Co., Ltd. were 11.09 billion Chinese Renmimbi (US$1.61 billion).
increase of 19.1%
versus 2015, when the company's sales were 9.32 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Jiangsu Hengrui Medicine Co., Ltd.
(and since 2011, sales have increased a total of 144%).
Sales of Medicinal Manufacturing saw an increase
21.2% in 2016, from
9.14 billion Chinese Renmimbi to 11.08 billion Chinese Renmimbi.
Not all segments of Jiangsu Hengrui Medicine Co., Ltd. experienced an increase in sales in 2016:
sales of Other Businesses fell 89.8% to 17.77 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).